JP2024531342A5 - - Google Patents
Info
- Publication number
- JP2024531342A5 JP2024531342A5 JP2024509397A JP2024509397A JP2024531342A5 JP 2024531342 A5 JP2024531342 A5 JP 2024531342A5 JP 2024509397 A JP2024509397 A JP 2024509397A JP 2024509397 A JP2024509397 A JP 2024509397A JP 2024531342 A5 JP2024531342 A5 JP 2024531342A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- antisense oligonucleotide
- oligonucleotide according
- therapeutic rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA202170418 | 2021-08-19 | ||
| DKPA202170418 | 2021-08-19 | ||
| PCT/EP2022/073188 WO2023021184A1 (en) | 2021-08-19 | 2022-08-19 | Antisense oligonucleotides targeting adenosine kinase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024531342A JP2024531342A (ja) | 2024-08-29 |
| JP2024531342A5 true JP2024531342A5 (https=) | 2025-08-05 |
Family
ID=83280116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509397A Pending JP2024531342A (ja) | 2021-08-19 | 2022-08-19 | アデノシンキナーゼを標的とするアンチセンスオリゴヌクレオチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250136990A1 (https=) |
| EP (1) | EP4388096A1 (https=) |
| JP (1) | JP2024531342A (https=) |
| CN (1) | CN118265785A (https=) |
| AU (1) | AU2022329462A1 (https=) |
| CA (1) | CA3228833A1 (https=) |
| WO (1) | WO2023021184A1 (https=) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4236812B2 (ja) | 1997-09-12 | 2009-03-11 | エクシコン エ／エス | オリゴヌクレオチド類似体 |
| KR20020013513A (ko) | 1999-03-18 | 2002-02-20 | 추후제출 | Ｘｙｌｏ-ｌｎａ 유사체 |
| DE60029314T2 (de) | 1999-03-24 | 2007-07-12 | Exiqon A/S | Verbesserte Synthese für -2.2.1. I Bicyclo-Nukleoside |
| AU7406700A (en) | 1999-10-04 | 2001-05-10 | Exiqon A/S | Design of high affinity rnase h recruiting oligonucleotide |
| JP4413493B2 (ja) | 2000-10-04 | 2010-02-10 | サンタリス ファーマ アー／エス | プリンｌｎａ類似体の改善された合成方法 |
| ATE287413T1 (de) | 2001-07-12 | 2005-02-15 | Santaris Pharma As | Verfahren zur herstellung des lna phosphoramidite |
| AU2003222743B2 (en) | 2002-05-08 | 2008-12-11 | Roche Innovation Center Copenhagen A/S | Synthesis of locked nucleic acid derivatives |
| US7481672B2 (en) | 2005-07-21 | 2009-01-27 | Rosemount Tank Radar Ab | Dielectric connector, DC-insulating through-connection and electronic system |
| WO2007031091A2 (en) | 2005-09-15 | 2007-03-22 | Santaris Pharma A/S | Rna antagonist compounds for the modulation of p21 ras expression |
| US20070203086A1 (en) * | 2006-02-24 | 2007-08-30 | Detlev Boison | Adenosine therapy via interfering RNA |
| EP2007888A2 (en) | 2006-04-03 | 2008-12-31 | Santaris Pharma A/S | Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| EP2753631A1 (en) | 2011-09-07 | 2014-07-16 | Marina Biotech, Inc. | Synthesis and uses of nucleic acid compounds with conformationally restricted monomers |
| MX2016005855A (es) | 2013-11-14 | 2016-07-13 | Roche Innovation Ct Copenhagen As | Compuestos de conjugados antisentido de apolipoproteina b (apob). |
| WO2022254021A1 (en) * | 2021-06-04 | 2022-12-08 | Neumirna Therapeutics Aps | Antisense oligonucleotides targeting adenosine kinase |
-
2022
- 2022-08-19 EP EP22768654.0A patent/EP4388096A1/en active Pending
- 2022-08-19 JP JP2024509397A patent/JP2024531342A/ja active Pending
- 2022-08-19 CN CN202280062861.5A patent/CN118265785A/zh active Pending
- 2022-08-19 WO PCT/EP2022/073188 patent/WO2023021184A1/en not_active Ceased
- 2022-08-19 US US18/683,659 patent/US20250136990A1/en active Pending
- 2022-08-19 CA CA3228833A patent/CA3228833A1/en active Pending
- 2022-08-19 AU AU2022329462A patent/AU2022329462A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2184375C (en) | Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties | |
| US5545729A (en) | Stabilized ribozyme analogs | |
| US7235653B2 (en) | Oligonucleotide compositions and methods for the modulation of the expression of B7 protein | |
| JP3585583B2 (ja) | 遺伝子発現を検出及び変調する糖修飾されたオリゴヌクレオチド | |
| JP5006485B2 (ja) | Ｒｎａを切断するオリゴリボヌクレオチドおよびリボヌクレアーゼ | |
| JP2021510511A5 (https=) | ||
| Liczner et al. | Beyond ribose and phosphate: selected nucleic acid modifications for structure–function investigations and therapeutic applications | |
| FI4220360T3 (fi) | Oligonukleotideja paternaalisen ube3a:n ilmentämiseksi | |
| JPH08508714A (ja) | オリゴヌクレオチド・アルキルホスホネートおよびアルキルホスホノチオエート | |
| AU2001289448B8 (en) | Chimeric antisense oligonucleotides of arabinofuranose analogues and deoxyribose nucleotides | |
| JP2024522272A5 (https=) | ||
| US7897582B2 (en) | Oligonucleotide compositions and methods for the modulation of the expression of B7 protein | |
| JP2024536132A5 (https=) | ||
| JP2024531342A5 (https=) | ||
| WO2007068113A1 (en) | 4'-thioarabinonucleotide-containing oligonucleotides, compounds and methods for their preparation and uses thereof | |
| Nurmi et al. | A modified X10-23 DNAzyme that can better access large, structured RNA targets | |
| CA2106015A1 (en) | Ribozymes having 2'-0 substituted nucleotides in the flanking sequences | |
| CN119790155A (zh) | 苏糖核酸反义寡核苷酸及其方法 | |
| CA3221935A1 (en) | Asymmetric short duplex dna as a novel gene silencing technology and use thereof | |
| CA3221923A1 (en) | Short duplex dna as a novel gene silencing technology and use thereof | |
| CN103597075A (zh) | 用于选择性地杀伤细胞的生物活性核苷酸分子、其用途及应用试剂盒 | |
| JP2022524218A5 (https=) | ||
| TW202019944A (zh) | 含有三硫代磷酸酯核苷間連接之寡核苷酸 | |
| EP3211081A1 (en) | Novel approach for treating inflammatory disorders | |
| HK40044075A (en) | Oligonucleotides comprising a phosphorotrithioate internucleoside linkage |